CRS(CRS)
CRS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.13B | $3.46B | $3.84B | $4.02B | $4.07B |
| Low | $3.12B | $3.40B | $3.82B | $3.95B | $4.00B |
| High | $3.14B | $3.52B | $3.86B | $4.10B | $4.16B |
| EBITDA Avg | $1.53B | $1.69B | $1.88B | $1.97B | $1.99B |
| Low | $1.53B | $1.66B | $1.87B | $1.93B | $1.95B |
| High | $1.54B | $1.72B | $1.88B | $2.00B | $2.03B |
| EBIT Avg | $1.47B | $1.62B | $1.80B | $1.88B | $1.91B |
| Low | $1.46B | $1.59B | $1.79B | $1.85B | $1.87B |
| High | $1.47B | $1.65B | $1.80B | $1.92B | $1.94B |
| Net Income Avg | $536M | $624M | $745M | $860M | $819M |
| Low | $531M | $622M | $724M | $839M | $798M |
| High | $541M | $655M | $830M | $883M | $840M |
| EPS Avg | $10.58 | $12.59 | $15.18 | $16.97 | $16.15 |
| Low | $10.48 | $12.26 | $14.28 | $16.55 | $15.75 |
| High | $10.67 | $12.91 | $16.37 | $17.41 | $16.57 |
| Analysts (Rev / EPS) | 5 / 5 | 6 / 5 | 5 / 5 | 2 / 1 | 2 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $862M | $819M | $807M | $902M | $958M | $899M | $886M | $977M |
| Low | $850M | $811M | $794M | $887M | $943M | $884M | $871M | $961M |
| High | $875M | $833M | $827M | $924M | $981M | $921M | $907M | $1.00B |
| EBITDA Avg | $421M | $400M | $394M | $441M | $468M | $439M | $433M | $477M |
| Low | $416M | $396M | $388M | $433M | $461M | $432M | $426M | $470M |
| High | $428M | $407M | $404M | $451M | $479M | $450M | $443M | $489M |
| EBIT Avg | $403M | $383M | $378M | $422M | $448M | $421M | $414M | $457M |
| Low | $398M | $379M | $372M | $415M | $441M | $414M | $408M | $450M |
| High | $409M | $390M | $387M | $432M | $459M | $431M | $424M | $468M |
| Net Income Avg | $155M | $139M | $140M | $170M | $188M | $176M | $176M | $207M |
| Low | $150M | $138M | $137M | $166M | $184M | $172M | $172M | $202M |
| High | $160M | $140M | $144M | $175M | $194M | $182M | $181M | $213M |
| EPS Avg | $3.07 | $2.77 | $2.78 | $3.38 | $3.73 | $3.50 | $3.49 | $4.11 |
| Low | $2.98 | $2.75 | $2.72 | $3.31 | $3.66 | $3.43 | $3.42 | $4.02 |
| High | $3.18 | $2.78 | $2.87 | $3.48 | $3.85 | $3.61 | $3.60 | $4.24 |
| Analysts (Rev / EPS) | 4 / 4 | 4 / 3 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 | 2 / 1 |